Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial
Jain, Preetesh, Keating, Michael, Renner, Sarah, Cleeland, Charles, Xuelin, Huang, Gonzalez, Graciela Nogueras, Harris, David, Li, Ping, Liu, Zhiming, Veletic, Ivo, Rozovski, Uri, Jain, Nitin, ThompsoVolume:
4
Language:
english
Journal:
The Lancet Haematology
DOI:
10.1016/S2352-3026(16)30194-6
Date:
February, 2017
File:
PDF, 347 KB
english, 2017